States say Purdue CEO should answer for role in opioid crisis

By Rick Archer (May 13, 2022, 7:33 p.m. EDT) – A group of state attorneys general have once again objected to proposed bonus payments for the CEO of Purdue Pharma LP, telling a bankruptcy judge in New York that it was part of the corporate culture that led to the national opioid crisis.

In a motion filed Wednesday, the 24-state and Washington, D.C. group said the court should reject Purdue’s request to pay CEO Craig Landau $3 million in performance-based bonuses, saying he didn’t had not taken action to stop Purdue’s opioid-related wrongdoing during the two decades he spent as one of the company’s executives.

“The need to remedy the failures of Dr. Landau…

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
  • Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and more!

TRY LAW360 FREE FOR SEVEN DAYS

Comments are closed.